U

Agalimmune

Anti-cancer immunotherapy platform
Startup Acquired United Kingdom
Last Update Jun 30, 2023

Agalimmune Financials

Undisclosed
Total funding
Capital raised
Undisclosed
Last funding
Acquired
Funding stage
0
Total rounds
0
Investors